Deep visual multi-omics profiling reveals mechanisms that underlie cancer cell differentiation and aggressiveness in clear cell renal cell carcinoma
Hella Anna BolckiD, Ede MighiD, András KristoniD, Natalia ZajaciD, Susanne KreutzeriD, Tiberiu TotuiD, Peter LearyiD, Ferenc KovácsiD, Dorothea RutishauseriD, Sibylle PfammatteriD, Jonas GrossmanniD, Cassandra LitchfieldiD, Marija BuljaniD, Niels J. RuppiD, Péter HorváthiD, Holger MochiD
Abstract
Clear cell renal cell carcinoma (ccRCC) exhibits significant intra-tumoral heterogeneity (ITH) at both morphological and genetic levels, complicating treatment and contributing to disease progression. Among these, ccRCCs with focal rhabdoid differentiation stand out as highly aggressive tumors distinguished by cells with unique morphological features. However, the correlation between distinct morphological phenotypes, specific molecular alterations, and their influence on tumor behavior remains poorly understood. In this study, we integrated advanced AI-based image analysis with single-cell isolation and multi-omics profiling to dissect the link between clinically relevant morphological and molecular features of ccRCC cells. Using a novel digital pathology workflow, we quantified low-grade, high-grade, and rhabdoid morphologies in ccRCC diagnostic images with unprecedented precision. Subsequently, isolation of two sets of 1,000 morphologically distinct cells for detailed mRNA and protein expression analyses, revealed significant increasing dysregulation associating with higher histopathological grades. Rhabdoid ccRCC cells (grade 4) demonstrated unique molecular profiles, including upregulated FOXM1-driven proliferation, disrupted cell-matrix interactions, and enhanced immune evasion pathways. Despite high T-cell infiltration in rhabdoid areas, we identified a rhabdoid-specific immunosuppressive network driven by cytokines, IFN-beta, and integrin signaling, likely contributing to T-cell exhaustion. Rhabdoid ccRCC cells develop a distinct immunosuppressive signaling network, involving PD-L1 and novel immunomodulatory factors such as CD38 and ITGB2. These findings provide a basis for novel therapeutic strategies targeting these pathways in combination with immunotherapy to improve outcomes for patients with aggressive rhabdoid ccRCC. Key PointsO_LIccRCC is characterized by well-established morphological heterogeneity but the correlation with the underlying molecular aberrations remained elusive. C_LIO_LIBy integrating AI-based image analysis with single cell isolation and deep multi-omics profiling, we dissect the molecular intricacies of ccRCC, from targeted collection of 1,000 morphologically distinct cells. C_LIO_LIOur results demonstrate significant dysregulation of gene and protein expression correlating with higher histopathological grades in ccRCC. C_LIO_LIAggressive ccRCC cells with rhabdoid differentiation (grade 4) display distinct molecular profiles, as they upregulate FOXM1-mediated proliferation, ECM remodeling and the immune evasion responses, suggesting new therapeutic avenues enhancing ICI efficacy in these patients. C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-Cell Multi-Omics Dissection of Malignant Evolutionary Mechanisms and Construction of a Prognostic Model for Clear Cell Renal Cell Carcinoma
Ruifei Liu, Yuchen Shi, … Jie Gao·bioRxiv·Jun 6, 2026
- Immune Classification of Clear Cell Renal Cell Carcinoma
S. Su, S. Akbarinejad, L. Shahriyari·bioRxiv·Jul 3, 2020
- A mosaic renal myeloid subtype with T-cell inhibitory and protumoral features is linked to immune escape and survival in clear cell renal cell cancer
D. Brech, T. Straub, … E. Noessner·bioRxiv·Jan 20, 2020
- The differentiation and functional landscape of tumor-resident CD8⁺ T cells shapes immunity and clinical outcomes in clear cell renal cell carcinoma
Sofía Hidalgo, Andrés Hernández‐Oliveras, … Álvaro Lladser·bioRxiv·Mar 15, 2026
- Multimodal cell communication networks nominate immunotherapies for RCC subgroups with discrete T cell recruitment or expansion
Jennifer Q. Pfeil, Shirley Hui, … Keith A. Lawson·bioRxiv·Aug 20, 2026
- Single-cell gene programs define subtype identity and metastatic trajectories in renal cell carcinoma
Ariel Madrigal, Minjun Kim, … Hamed Shateri Najafabadi·medRxiv·Jul 16, 2026